株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界のバイオ医薬品バイオセパレーションシステム市場

Biopharmaceutical Bioseparation Systems

発行 Global Industry Analysts, Inc. 商品コード 352665
出版日 ページ情報 英文 294 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.76円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
世界のバイオ医薬品バイオセパレーションシステム市場 Biopharmaceutical Bioseparation Systems
出版日: 2018年02月01日 ページ情報: 英文 294 Pages
概要

当レポートでは、世界のバイオ医薬品バイオセパレーションシステム市場について調査分析し、製品セグメント別、地域 (米国、カナダ、日本、欧州、アジア太平洋地域、中東・アフリカ、ラテンアメリカ) 別に、市場実績と予測、主要企業プロファイルなど、体系的な情報を提供しています。

第1章 イントロダクション、調査手法、製品の定義

第2章 エグゼクティブサマリー

  • 見通し
    • バイオセパレーションシステム
    • 米国が市場リーダー
    • クロマトグラフィー
    • 競合情勢
  • 産業概要
  • バイオセパレーション技術:主な市場動向
  • 製品概要
    • 生物学的製品:概要
    • バイオセパレーション:概要
    • バイオセパレーション:課題が多く、複雑で高額なプロセス
    • 主なバイオセパレーション技術、など
  • 製品の紹介/承認
  • 最近の産業活動
  • 世界の主要企業
    • 3M Company (米国)
    • Agilent Technologies, Inc. (米国)
    • Alfa Wassermann Separation Technologies, LLC (米国)
    • Flottweg Separation Technology (米国)
    • GEA Westfalia Separator Group GmbH (ドイツ)
    • GE Healthcare Life Sciences (米国)
    • KNAUER Wissenschaftliche Gerate GmbH (ドイツ)
    • Konik Nanobiotech SL (スペイン)
    • Merck KGaA (ドイツ)
    • Pall Corporation (米国)
    • ProMetic Life Sciences, Inc. (カナダ)
    • Sartorius Stedim Biotech (フランス)
    • Repligen Corporation (米国)
    • Thermo Fisher Scientific, Inc. (米国)
    • Tosoh Bioscience, Inc. (日本)
    • YMC Europe GmbH (ドイツ)
  • 世界市場の見通し

第3章 市場

  • 米国
  • カナダ
  • 日本
  • 欧州
  • アジア太平洋地域
  • 中東・アフリカ
  • ラテンアメリカ

第4章 競合情勢

  • 企業プロファイル:57社 (事業部/子会社を含めると68社)
    • 米国
    • カナダ
    • 日本
    • 欧州
    • アジア太平洋地域 (日本を除く)
目次
Product Code: MCP-7973

This report analyzes the worldwide markets for Biopharmaceutical Bioseparation Systems in US$ Million by the following Product Segments: Chromatography Systems, and Other Bioseparation Systems. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 57 companies including many key and niche players such as -

3M Company
Agilent Technologies, Inc.
Alfa Wassermann Separation Technologies, LLC
Flottweg Separation Technology
GEA Westfalia Separator Group GmbH
GE Healthcare Life Sciences

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations

Disclaimers

Data Interpretation & Reporting Level

  • Quantitative Techniques & Analytics

Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. OUTLOOK

  • Bioseparation Systems - Invaluable Tools in Biopharmaceutical Manufacturing
  • US Remains Market Leader; Developing Countries to Drive Market Growth
  • Chromatography Leads the Pack
  • Global Market for Gas Chromatography Systems
  • Competitive Landscape
    • Table 1: Leading Players in the Global Biopharmaceutical Bioseparation Systems Market (2017): Percentage Market Share Breakdown of Revenues for 3M Purification, GE Healthcare Life Sciences, Merck, Pall Corporation, Sartorius and Others (includes corresponding Graph/Chart)

2. INDUSTRY OVERVIEW

  • A Peek into Biopharmaceutical Manufacturing
  • Downstream Processing of Biosynthetic Products - An Overview
  • Growing Biopharmaceutical Market Drives Demand for Bioseparation Systems
    • Table 2: Top 10 Biopharmaceutical Companies: 2016 (includes corresponding Graph/Chart)
    • Table 3: CDER NME NDAs/BLAs Filings and Approvals: As of November 30, 2017 (includes corresponding Graph/Chart)
  • New Biologic License Application (BLA) Approvals-2017
  • New Biologic License Application (BLA) Approvals: 2016
  • New Biologic License Application (BLA) Approval: 2015
  • Biopharmaceutical Industry Transforms Downstream Processing
  • Growing Biological Drug Manufacturing Capacity to Drive Growth
  • Growing Market for Monoclonal Antibodies - A Key Review of Current Status and Future Prospects
  • Approved Monoclonal Antibodies: 2014-2017
  • An Insight into Bioseparation of mAbs
  • Growing Biosimilars Market - A Clear Advantage for Bioseparation Technologies
  • Patent Expiries of Major Biopharmaceutical Drugs in the US and Europe
  • US APPROVED BIOSIMILARS AS OF DECEMBER 2017
  • EUROPE APPROVED BIOSIMILARS AS OF DECEMBER 2017
  • R&D Funding Crucial for Biologics and Bioseparation Market
  • Huge Biopharmaceutical Pipeline - A Clear Indicator of Future Prospects
    • Table 4: Biopharmaceutical Products' Pipeline by Therapeutic Category: As of August, 2016 (includes corresponding Graph/Chart)
    • Table 5: Biopharmaceutical Products' Pipeline by Clinical Phase: As of August, 2016 (includes corresponding Graph/Chart)
    • Table 6: Biopharmaceutical Cancer Products Pipeline: As of August, 2016 (includes corresponding Graph/Chart)

3. BIOSEPARATION TECHNOLOGIES - KEY MARKET TRENDS

  • Increasing Need for Further Advances in Downstream Processing Techniques
  • Process Optimization and Cost Reduction - Key Goals of Innovations in Bioseparation
  • Continuous Bioseparation Gains Momentum
  • Process Intensification
  • Single-Use Systems Play a Key Role
  • Minimizing Centrifugation Steps
  • Integration of Down-Stream and Up-Stream
  • Developmental Efforts
  • Focus on Enhancing Capture Increases
  • Introduction of Diversified Resins on the Rise
  • Multicolumn System Lower Buffer and Resin Requirement
  • Single-Use Disposable Technologies Gain Attention
  • Select Commercial Disposable/Single-Use Technologies by Process Technique
  • Innovations in Single-use Systems
  • Increasing Biopharma Productivity and Efficiency via Continuous Manufacturing
  • Changing Paradigm of Primary Recovery in Bioseparation
  • Growing Use of Membrane Filtration in Biopharmaceutical Manufacturing
  • Chromatography - The Gold Standard Purification Technology
  • Continuous Chromatography- A Key Technology for the Biopharma Sector
    • Challenges to Separate Active Pharmaceutical Ingredients, Chromatography to the Rescue
  • Inherent Benefits of Membrane Chromatography to Drive its Use in Bioprocessing
  • SMBC - An Old Approach Gaining Significant Attention
  • Superior Efficiency Drives Use of Synthetic Ligands in Affinity Chromatography
    • A Comparison of Protein and Synthetic Ligands
  • Increasing Alternatives to Protein A Column based Capturing
  • Twin-Column SMB - An Emerging Alternative to Protein A Columns
  • Chiral Chromatography Increases in Popularity
  • Flexible and Selective Chromatography Improves Biopharmaceutical Efficiencies
  • Chromatography Efficiency and Selectivity
  • Mixed-Mode Chromatography
  • Multimode Chromatography
  • Mixed-Mode and Multimode Media Offer Cost Savings
  • Awareness of Mixed Mode and Multimode Media Operating Modes Critical
  • Magnetic Separation as an Alternative to Chromatography - A Review
  • Reversible Precipitation - A Novel Bioseparation Technology

4. PRODUCT OVERVIEW

  • Biological Products - An Overview
  • Classification of Biological Products by Application
  • Classification of Biological Products by Chemical Nature
  • Bioseparation - An Overview
  • Commonly Used Bioseparation Processes by Factors
  • Bioseparation - A Challenging, Complex, and Expensive Process
  • Stages of Biomolecule Recovery and Relevant Bioseparation Techniques Used
  • Classification of Bioseparation Techniques based on Resolution and Throughput
  • Bioseparation Costs as a Percentage of Processing by Biological Product
  • Key Bioseparation Techniques
  • Chromatography
  • Centrifugation
  • Membrane Separation
  • Filtration
  • Overview of Other Bioseparation Techniques
  • Adsorption
  • Extraction
  • Precipitation
  • Classification of Bioseparation Techniques based on Physical Form
  • Particle-Liquid Separation
  • Particle-Particle Separation
  • Solute-Solvent Separation
  • Solute-Solute Separation
  • Liquid-Liquid Separation
  • Particle-Solute Separation
  • RIPP in Bioseparation - The Conventional Scheme for Developing Processes

5. PRODUCT INTRODUCTIONS/APPROVALS

  • GE Healthcare Introduces MabSelect PrismA
  • Pall Introduces Flexible Single-use Chromatography System
  • MilliporeSigma Launches Eshmuno Affinity Chromatography Resins
  • PerkinElmer Introduces Clarus 590 and 690 GC Instruments
  • Sartorius Stedim Biotech Releases Sartobind Cassettes
  • Ellutia Chromatography Solutions Unveils 500 Series Range of Instruments
  • Kaneka Corporation Launches KANEKA KanCapA 3G
  • Pall Life Sciences Introduces Cadence BioSMB Process System
  • Thermo Fisher Exhibits SMART Digest Kit
  • Merck Launches Wide Range of Products for Separation and Analysis
  • Agilent Technologies Introduces New Line of AdvanceBio SEC Columns

6. RECENT INDUSTRY ACTIVITY

  • Waters Corp. Launches ACQUITY Arc Bio System
  • GE Healthcare Acquires Puridify
  • MilliporeSigma Inks MoU with Samsung BioLogics
  • Merck Acquires Natrix Separations
  • Repligen Merges with Spectrum Labs
  • Waters Enters into a Co-Marketing Agreement with Wyatt Technology
  • JLS Expands Amsphere A3 Production Capacity
  • YMC Buys Land in the Annex Kyoto Miwa Industrial Park
  • KNAUER and 3B Pharmaceuticals Delivers Purification Process for Camelid Antibodies
  • ATG Enters into a Service Agreement with LEWA-Nikkiso America
  • Repligen Buys Atoll
  • Pall Enters into a Supply Agreement with KANEKA
  • Merck Acquires Sigma-Aldrich
  • EMD Millipore Launches Sterilizing-Grade Millipore Express(r) PHF Hydrophilic Filters
  • Anteo Diagnostics Inks South Korean Distribution Agreement with KomaBiotech
  • GE Healthcare and Sartorius Stedim Biotech Ink OEM Supply Agreement for Sartobind(tm) Technology
  • EMD Millipore Unveils Pellicon(r) Tangential Flow Filtration System
  • ImmunoReagents and ProteoVec Launch PV-Pure Ig(tm) Antibody Purification Kits
  • Pall Acquires Tarpon's BioSMB Platform

7. FOCUS ON SELECT PLAYERS

  • 3M Company (USA)
  • 3M Purification, Inc. (USA)
  • Agilent Technologies, Inc. (USA)
  • Alfa Wassermann Separation Technologies, LLC (USA)
  • Flottweg Separation Technology (USA)
  • GEA Westfalia Separator Group GmbH (Germany)
  • GE Healthcare Life Sciences (USA)
  • KNAUER Wissenschaftliche Gerate GmbH (Germany)
  • Konik Nanobiotech SL (Spain)
  • Merck KGaA (Germany)
  • Pall Corporation (USA)
  • ProMetic Life Sciences, Inc. (Canada)
  • Sartorius Stedim Biotech (France)
  • Repligen Corporation (USA)
  • Thermo Fisher Scientific, Inc. (USA)
  • Tosoh Bioscience, Inc. (Japan)
  • YMC Europe GmbH (Germany)

8. GLOBAL MARKET PERSPECTIVE

    • Table 7: World Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 8: World Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 9: World 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin America Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 10: World Recent Past, Current & Future Analysis for Chromatography Systems for Biopharmaceutical Bioseparation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 11: World Historic Review for Chromatography Systems for Biopharmaceutical Bioseparation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 12: World 14-Year Perspective for Chromatography Systems for Biopharmaceutical Bioseparation by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin America Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 13: World Recent Past, Current & Future Analysis for Other Biopharmaceutical Bioseparation Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 14: World Historic Review for Other Biopharmaceutical Bioseparation Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 15: World 14-Year Perspective for Other Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin America Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • United States: The Largest Biopharmaceutical Market Globally
    • Table 16: CDER NME NDAs/BLAs Filings and Approvals as of 11/30/17 (includes corresponding Graph/Chart)
    • Impending Patent Expiries Signal Growth Prospects
      • Leading US Biopharmaceuticals by Year of Patent Expiry
    • Product Launches
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 17: The US Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 18: The US Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 19: The US 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Current & Future Analysis
    • Canada - A Lucrative Biopharmaceutical Industry
    • Strategic Corporate Development
    • Select Key Player
  • B. Market Analytics
    • Table 20: Canadian Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 21: Canadian Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 22: Canadian 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Current & Future Analysis
    • Product Launch
    • Strategic Corporate Developments
    • Select Key Player
  • B. Market Analytics
    • Table 23: Japanese Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 24: Japanese Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 25: Japanese 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Current & Future Analysis
    • Select Trends in the European Biopharmaceutical Industry
      • Funding Challenges Faced by Biopharmaceutical Startups
      • Healthcare Agencies Embrace Biosimilars to Cut Healthcare Costs
  • B. Market Analytics
    • Table 26: European Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 27: European Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 28: European 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 29: European Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 30: European Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 31: European 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Current & Future Analysis
    • Select Key Player
  • B. Market Analytics
    • Table 32: French Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 33: French Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 34: French 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Current & Future Analysis
    • Product Launch
    • Strategic Corporate Development
    • Select Key Players
  • B. Market Analytics
    • Table 35: German Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 36: German Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 37: German 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4c. ITALY

  • Market Analysis
    • Table 38: Italian Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 39: Italian Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 40: Italian 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Current & Future Analysis
    • Product Launch
    • Strategic Corporate Developments
  • B. Market Analytics
    • Table 41: The UK Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 42: The UK Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 43: The UK 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4e. SPAIN

  • A. Market Analysis
    • Current & Future Analysis
    • Select Key Player
  • B. Market Analytics
    • Table 44: Spanish Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 45: Spanish Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 46: Spanish 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4f. RUSSIA

  • A. Market Analysis
    • Current & Future Analysis
  • B. Market Analytics
    • Table 47: Russian Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 48: Russian Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 49: Russian 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • A. Market Analysis
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 50: Rest of Europe Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 51: Rest of Europe Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 52: Rest of Europe 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Current & Future Analysis
    • Regional Biopharma Players Gain Strength by Innovation and Partnerships
    • Asia Set to Emerge as Preferred Outsourcing Destination for Biopharma Manufacturing
    • Availability of Scientific Talent - Major Advantage for India
  • B. Market Analytics
    • Table 53: Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 54: Asia-Pacific Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 55: Asia-Pacific 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Revenues for China, India and Rest of Asia-Pacific Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 56: Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 57: Asia-Pacific Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 58: Asia-Pacific 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

5a. CHINA

  • Market Analysis
    • Table 59: Chinese Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 60: Chinese Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 61: Chinese 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

5b. INDIA

  • Market Analysis
    • Table 62: Indian Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 63: Indian Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 64: Indian 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

5c. REST OF ASIA-PACIFIC

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 66: Rest of Asia-Pacific Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 67: Rest of Asia-Pacific 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

6. THE MIDDLE EAST & AFRICA

  • Market Analysis
    • Table 68: The Middle East & African Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 69: The Middle East & African Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 70: The Middle East & African 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

7. LATIN AMERICA

  • Market Analysis
    • Table 71: Latin American Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 72: Latin American Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 73: Latin American 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Revenues for Brazil and Rest of Latin American Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 74: Latin American Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 75: Latin American Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 76: Latin American 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

7a. BRAZIL

  • Market Analysis
    • Table 77: Brazilian Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 78: Brazilian Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 79: Brazilian 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

7b. REST OF LATIN AMERICA

  • Market Analysis
    • Table 80: Rest of Latin American Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 81: Rest of Latin American Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 82: Rest of Latin American 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
Back to Top